Immunoprecise AntibodiesIPA
IPA
$0.6700
0.74%
Market Cap: $18.7M
0
Funds holding %
of 6,728 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
225% more call options, than puts
Call options by funds: $26K | Put options by funds: $8K
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0.1% less ownership
Funds ownership: 6.39% [Q1] → 6.29% (-0.1%) [Q2]
14% less funds holding
Funds holding: 22 [Q1] → 19 (-3) [Q2]
35% less capital invested
Capital invested by funds: $2.56M [Q1] → $1.68M (-$883K) [Q2]
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
348%
upside
Avg. target
$7
945%
upside
High target
$9
1,243%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Swayampakula Ramakanth 31% 1-year accuracy 42 / 136 met price target | 1,243%upside $9 | Buy Reiterated | 17 Sept 2024 |
Benchmark Robert Wasserman 55% 1-year accuracy 24 / 44 met price target | 348%upside $3 | Speculative Buy Maintained | 14 Aug 2024 |
HC Wainwright & Co. Swayampakula Ramakanth 31% 1-year accuracy 42 / 136 met price target | 1,243%upside $9 | Buy Reiterated | 30 Jul 2024 |
Financial journalist opinion
Based on 6 articles about IPA published over the past 30 days